Literature DB >> 29882096

[Locoregional hyperthermia improves disease-specific overall survival in combination with neoadjuvant chemotherapy in high-risk soft tissue sarcomas].

Franziska Eckert1, Daniel Zips2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29882096     DOI： 10.1007/s00066-018-1322-2

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Authors:  Rolf D Issels; Lars H Lindner; Jaap Verweij; Peter Wust; Peter Reichardt; Baard-Christian Schem; Sultan Abdel-Rahman; Soeren Daugaard; Christoph Salat; Clemens-Martin Wendtner; Zeljko Vujaskovic; Rüdiger Wessalowski; Karl-Walter Jauch; Hans Roland Dürr; Ferdinand Ploner; Andrea Baur-Melnyk; Ulrich Mansmann; Wolfgang Hiddemann; Jean-Yves Blay; Peter Hohenberger
Journal:  Lancet Oncol       Date:  2010-04-29       Impact factor: 41.316

2.  Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas.

Authors:  Franziska Eckert; Lore Helene Braun; Frank Traub; Hans-Georg Kopp; Bence Sipos; Ulf Lamprecht; Arndt-Christian Müller; Frank Paulsen; Daniel Zips
Journal:  Int J Hyperthermia       Date:  2017-09-05       Impact factor: 3.914

Review 3.  European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas.

Authors:  Jean-Yves Blay; Mehdi Brahmi; Isabelle Ray-Coquard
Journal:  Eur J Cancer       Date:  2016-11-24       Impact factor: 9.162

4.  Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

Authors:  A Le Cesne; M Ouali; M G Leahy; A Santoro; H J Hoekstra; P Hohenberger; F Van Coevorden; P Rutkowski; R Van Hoesel; J Verweij; S Bonvalot; W P Steward; A Gronchi; P C W Hogendoorn; S Litiere; S Marreaud; J Y Blay; W T A Van Der Graaf
Journal:  Ann Oncol       Date:  2014-10-06       Impact factor: 32.976

5.  Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.

Authors:  Martin K Angele; Markus Albertsmeier; Niclas J Prix; Peter Hohenberger; Sultan Abdel-Rahman; Nelli Dieterle; Michael Schmidt; Ulrich Mansmann; Christiane J Bruns; Rolf D Issels; Karl-Walter Jauch; Lars H Lindner
Journal:  Ann Surg       Date:  2014-11       Impact factor: 12.969

6.  Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy With Hyperthermia in Improved Outcomes in Patients With Sarcoma.

Authors:  Mark W Dewhirst; David Kirsch
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

7.  Sarcoma: Local hyperthermia improves survival.

Authors:  David Killock
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

8.  Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial.

Authors:  Rolf D Issels; Lars H Lindner; Jaap Verweij; Rüdiger Wessalowski; Peter Reichardt; Peter Wust; Pirus Ghadjar; Peter Hohenberger; Martin Angele; Christoph Salat; Zeljko Vujaskovic; Soeren Daugaard; Olav Mella; Ulrich Mansmann; Hans Roland Dürr; Thomas Knösel; Sultan Abdel-Rahman; Michael Schmidt; Wolfgang Hiddemann; Karl-Walter Jauch; Claus Belka; Alessandro Gronchi
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.